{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T11:21:16Z","timestamp":1767612076131},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,30]]},"DOI":"10.7759\/cureus.25482","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T13:51:36Z","timestamp":1653918696000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case Report of Large Bilateral Pulmonary Embolism in a Patient With Janus Kinase 2 (JAK2) Positive Mutation"],"prefix":"10.7759","author":[{"given":"Zahid","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Besis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07537.x","article-title":"Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms","volume":"144","author":"Za T","year":"2009","unstructured":"Za T, Fiorini A, Rossi E, Ciminello A, Chiusolo P, Leone G, De Stefano V. Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms. Br J Haematol. 2009, 144:965-7. 10.1111\/j.1365-2141.2008.07537.x","journal-title":"Br J Haematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmv.2014.02.005","article-title":"Recurrent deep vein thrombosis and myeloproliferative syndrom: emergence of JAK2 mutation five years after the initial event","volume":"39","author":"Salort A","year":"2014","unstructured":"Salort A, Seinturier C, Molina L, L\u00e9v\u00e8que P, Imbert B, Pernod G. Recurrent deep vein thrombosis and myeloproliferative syndrom: emergence of JAK2 mutation five years after the initial event. J Mal Vasc. 2014, 39:207-11. 10.1016\/j.jmv.2014.02.005","journal-title":"J Mal Vasc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2012-008214","article-title":"Intracardiac thrombosis in polycythemia vera","volume":"2013","author":"Gangadharamurthy D","year":"2013","unstructured":"Gangadharamurthy D, Shih H. Intracardiac thrombosis in polycythemia vera. BMJ Case Rep. 2013, 2013:bcr2012008214. 10.1136\/bcr-2012-008214","journal-title":"BMJ Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-218851","article-title":"Bumpy road to the diagnosis of polycythaemia vera","volume":"2017","author":"Gameiro RS","year":"2017","unstructured":"Gameiro RS, Rodrigues A, Gon\u00e7alves FM, Gra\u00e7a JP. Bumpy road to the diagnosis of polycythaemia vera. BMJ Case Rep. 2017, 2017:bcr2016218851. 10.1136\/bcr-2016-218851","journal-title":"BMJ Case Rep"},{"key":"ref5","article-title":"Portal vein thrombosis as the main symptom of unclassified JAK2-positive myeloproliferative neoplasm--case report","volume":"33","author":"Karakulska-Prystupiuk E","year":"2012","unstructured":"Karakulska-Prystupiuk E, Gierej B, Paszkowska-Kowalewska M, Wilkowojska U, Jedrzejczak WW. Portal vein thrombosis as the main symptom of unclassified JAK2-positive myeloproliferative neoplasm--case report. Pol Merkur Lekarski. 2012, 33:29-31.","journal-title":"Pol Merkur Lekarski"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber DA","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, et al.. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016, 127:2391-405. 10.1182\/blood-2016-03-643544","journal-title":"Blood"},{"key":"ref7","unstructured":"Polycythemia vera diagnostic criteria. (2016). Accessed. April 29, 2022: https:\/\/www.wikidoc.org\/index.php\/Polycythemia_vera_diagnostic_criteria."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-460154","article-title":"Myeloproliferative neoplasms and thrombosis","volume":"122","author":"Barbui T","year":"2013","unstructured":"Barbui T, Finazzi G, Falanga A. Myeloproliferative neoplasms and thrombosis. Blood. 2013, 122:2176-84. 10.1182\/blood-2013-03-460154","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-009-0319-3","article-title":"Insights into the pathogenesis and management of thrombosis in polycythemia vera and essential thrombocythemia","volume":"5","author":"Vannucchi AM","year":"2010","unstructured":"Vannucchi AM. Insights into the pathogenesis and management of thrombosis in polycythemia vera and essential thrombocythemia. Intern Emerg Med. 2010, 5:177-84. 10.1007\/s11739-009-0319-3","journal-title":"Intern Emerg Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-976165","article-title":"Thrombosis in myeloproliferative disorders: prevalence, prognostic factors, and the role of leukocytes and JAK2V617F","volume":"33","author":"Tefferi A","year":"2007","unstructured":"Tefferi A, Elliott M. Thrombosis in myeloproliferative disorders: prevalence, prognostic factors, and the role of leukocytes and JAK2V617F. Semin Thromb Hemost. 2007, 33:313-20. 10.1055\/s-2007-976165","journal-title":"Semin Thromb Hemost"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-9-199511010-00003","article-title":"Polycythemia vera: the natural history of 1213 patients followed for 20 years","volume":"123","author":"Gruppo Italiano Studio Policitemia","year":"1995","unstructured":"Gruppo Italiano Studio Policitemia. Polycythemia vera: the natural history of 1213 patients followed for 20 years. Ann Intern Med. 1995, 123:656-64. 10.7326\/0003-4819-123-9-199511010-00003","journal-title":"Ann Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15648","article-title":"A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline","volume":"184","author":"McMullin MF","year":"2019","unstructured":"McMullin MF, Harrison CN, Ali S, et al.. A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline. Br J Haematol. 2019, 184:176-91. 10.1111\/bjh.15648","journal-title":"Br J Haematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4046\/trd.2009.67.4.351","article-title":"A case of pulmonary thromboembolism with JAK2 mutation","volume":"67","author":"Kim JJ","year":"2009","unstructured":"Kim JJ, Kwon SS, Lee HJ, Lee HY, Jeong MH, Kim YH. A case of pulmonary thromboembolism with JAK2 mutation. Tuber Respir Dis. 2009, 67:351. 10.4046\/trd.2009.67.4.351","journal-title":"Tuber Respir Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2002.33756","article-title":"The risk of thrombosis in essential thrombocythemia and polycythemia vera","volume":"29","author":"Pearson TC","year":"2002","unstructured":"Pearson TC. The risk of thrombosis in essential thrombocythemia and polycythemia vera. Semin Oncol. 2002, 29:16-21. 10.1053\/sonc.2002.33756","journal-title":"Semin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12053","article-title":"Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments","volume":"93","author":"De Stefano V","year":"2008","unstructured":"De Stefano V, Za T, Rossi E, et al.. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments. Haematologica. 2008, 93:372-80. 10.3324\/haematol.12053","journal-title":"Haematologica"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.07.062","article-title":"Vascular and neoplastic risk in a large cohort of patients with polycythemia vera","volume":"23","author":"Marchioli R","year":"2005","unstructured":"Marchioli R, Finazzi G, Landolfi R, et al.. Vascular and neoplastic risk in a large cohort of patients with polycythemia vera. J Clin Oncol. 2005, 23:2224-32. 10.1200\/JCO.2005.07.062","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/96848-a-case-report-of-large-bilateral-pulmonary-embolism-in-a-patient-with-janus-kinase-2-jak2-positive-mutation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:10Z","timestamp":1707507370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/96848-a-case-report-of-large-bilateral-pulmonary-embolism-in-a-patient-with-janus-kinase-2-jak2-positive-mutation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,30]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.25482","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,30]]}}}